Browse Arkansas Code titles and sections
21 U.S.C. § 1712 — Repealed. Pub. L. 115–271, title VIII, § 8202(b)(2), Oct. 24, 2018, 132 Stat. 4110
Federal law — U.S. Code and appendices · legal_authorities
### Statutory Notes
Section, Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), Oct. 24, 2018, 132 Stat. 4110, provided for the termination of Office of National Drug Control Policy and repealed this chapter effective Sept. 30, 2010.
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1712
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: b8b830d16bbd2ba0764c2736517198351eeddc3390468628d7db66ddd0c531d6. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:record_usc_2db07d016dbd5237d757acd5
Source file: Laws/federal/codes/united-states-code/title-21/section-1712-repealed-pub-l-115271-title-viii-8202-b-2-oct-24-2018-132-stat-4110--4d66cb3114.md
Pages: Not recorded – Not recorded
Passage SHA-256: bcdbd64795b6fefdc07ae7d26c1ffff69ba374c7d1872014c15400ec34cbed62
Source location: Title 21, Chapter 22, § 1712; chapter-022-national-drug-control-policy.md
Stored source content
### Statutory Notes
Section, Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), Oct. 24, 2018, 132 Stat. 4110, provided for the termination of Office of National Drug Control Policy and repealed this chapter effective Sept. 30, 2010.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
In this chapter:
(1) **Agency** — The term “agency” has the meaning given the term “executive agency” in [section 102 of title 31](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section102&num=0&edition=prelim).
(2) **Appropriate congressional committees**
(A) *In general* — The term “appropriate congressional committees” means—
(i) the Committee on the Judiciary, the Committee on Appropriations, and the Committee on Health, Education, Labor, and Pensions of the Senate; and
(ii) the Committee on Oversight and Government Reform, the Committee on the Judiciary, the Committee on Energy and Commerce, and the Committee on Appropriations of the House of Representatives.
(B) *Submission to Congress* — Any submission to Congress shall mean submission to the appropriate congressional committees.
(3) **Demand reduction** — The term “demand reduction” means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce or prevent the use of drugs or support, expand, or provide treatment and recovery efforts, including—
(A) education about the dangers of illicit drug use;
(B) services, programs, or strategies to prevent substance use disorder, including evidence-based education campaigns, community-based prevention programs, collection and disposal of unused prescription drugs, and services to at-risk populations to prevent or delay initial use of an illicit drug;
(C) substance use disorder treatment;
(D) support for long-term recovery from substance use disorders;
(E) drug-free workplace programs;
(F) drug testing, including the testing of employees;
(G) interventions for illicit drug use and dependence;
(H) expanding availability of access to health c
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1701
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment of Office** There is established in the Executive Office of the President an Office of National Drug Control Policy, which shall—
(1) lead the national drug control effort, including coordinating with the National Drug Control Program agencies;
(2) coordinate and oversee the implementation of the national drug control policy, including the National Drug Control Strategy;
(3) assess and certify the adequacy of National Drug Control Programs and the budget for those programs;
(4) evaluate the effectiveness of national drug control policy efforts, including the National Drug Control Program Agencies’ 11 So in original. Probably should be “agencies’ ”. programs, by developing and applying specific goals and performance measurements and monitoring the agencies’ program-level spending;
(5) identify and respond to emerging drug threats related to illicit drug use;
(6) administer the Drug-Free Communities Program, the High Intensity Drug Trafficking Areas Program, and other grant programs directly authorized to be administered by the Office in furtherance of the National Drug Control Strategy; and
(7) facilitate broad-scale information sharing and data standardization among Federal, State, and local entities to support the national drug control efforts.
**(b) Repealed. Pub. L. 115–271, title VIII, § 8222(1), Oct. 24, 2018, 132 Stat. 4142**
**(c) Access by Congress** The location of the Office in the Executive Office of the President shall not be construed as affecting access by Congress, or any committee of the House of Representatives or the Senate, to any—
(1) information, document, or study in the possession of, or conducted by or at the direction of the Director; or
(2) personnel of the Office.
**(d) Office of National Drug Control Policy Gif
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1702
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Appointment**
(1) **In general**
(A) *Director*
(i) *In general* — There shall be at the head of the Office a Director who shall hold the same rank and status as the head of an executive department listed in [section 101 of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section101&num=0&edition=prelim).
(ii) *Appointment* — The Director shall be appointed by the President, by and with the advice and consent of the Senate, and shall serve at the pleasure of the President.
(B) *Deputy Director* — There shall be a Deputy Director who shall report directly to the Director, and who shall be appointed by the President, and shall serve at the pleasure of the President.
(C) *Coordinators* — The following coordinators shall be appointed by the Director:
(i) Performance Budget Coordinator, as described in subsection (c)(5).
(ii) Interdiction Coordinator, as described in [section 1710 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1710&num=0&edition=prelim).
(iii) Emerging and Continuing Threats Coordinator, as described in [section 1708 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1708&num=0&edition=prelim).
(iv) State, Local, and Tribal Affairs Coordinator, to carry out the activities described in subsection (j).
(v) Demand Reduction Coordinator, as described in subparagraph (D).
(D) *Demand Reduction Coordinator* — The Director shall designate or appoint a United States Demand Reduction Coordinator to be responsible for the activities described in [section 1701(3) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1701/3&num=0&edition=prelim). For purposes of carrying
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1703
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Access to information**
(1) **In general** — Upon the request of the Director, the head of any National Drug Control Program agency shall cooperate with and provide to the Director any statistics, studies, reports, and other information prepared or collected by the agency concerning the responsibilities of the agency under the National Drug Control Strategy that relate to—
(A) drug control; or
(B) the manner in which amounts made available to that agency for drug control are being used by that agency.
(2) **Protection of intelligence information**
(A) *In general* — The authorities conferred on the Office and the Director by this chapter shall be exercised in a manner consistent with provisions of the National Security Act of 1947 [[50 U.S.C. 3001](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title50-section3001&num=0&edition=prelim) et seq.]. The Director of National Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this chapter regarding intelligence sources and methods.
(B) *Duties of Director* — The Director of National Intelligence and the Director of the Central Intelligence Agency shall, to the maximum extent practicable in accordance with subparagraph (A), render full assistance and support to the Office and the Director.
(3) **Required reports**
(A) *Secretaries of the Interior and Agriculture* — Not later than July 1 of each year, the Secretaries of Agriculture and the Interior shall jointly submit to the Director and the appropriate congressional committees an assessment of the quantity of illegal drug cultivation and manufacturing in the United States on lands owned or under the jurisdiction of the Federal Government for the preceding year.
(B) *Secretary o
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1704
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) In general**
(1) **Statement of drug policy priorities** — The Director shall release a statement of drug control policy priorities in the calendar year of a Presidential inauguration following the inauguration, but not later than April 1.
(2) **National Drug Control Strategy submitted by the President** — Not later than the first Monday in February following the year in which the term of the President commences, and every 2 years thereafter, the President shall submit to Congress a National Drug Control Strategy.
**(b) Development of the National Drug Control Strategy**
(1) **Promulgation** — The Director shall promulgate the National Drug Control Strategy, which shall set forth a comprehensive plan to reduce illicit drug use and the consequences of such illicit drug use in the United States by limiting the availability of and reducing the demand for illegal drugs and promoting prevention, early intervention, treatment, and recovery support for individuals with substance use disorders.
(2) **State and local commitment** — The Director shall seek the support and commitment of State, local, and Tribal officials in the formulation and implementation of the National Drug Control Strategy.
(3) **Strategy based on evidence** — The Director shall ensure the National Drug Control Strategy is based on the best available evidence regarding the policies that are most effective in reducing the demand for and supply of illegal drugs.
(4) **Process for development and submission of National Drug Control Strategy** — In developing and effectively implementing the National Drug Control Strategy, the Director—
(A) shall consult with—
(i) the heads of the National Drug Control Program agencies;
(ii) each Coordinator listed in [section 1703 of this title](https:
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1705
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment**
(1) **In general** — There is established in the Office a program to be known as the High Intensity Drug Trafficking Areas Program (in this section referred to as the “Program”).
(2) **Purpose** — The purpose of the Program is to reduce drug trafficking and drug production in the United States by—
(A) facilitating cooperation among Federal, State, local, and tribal law enforcement agencies to share information and implement coordinated enforcement activities;
(B) enhancing law enforcement intelligence sharing among Federal, State, local, and tribal law enforcement agencies;
(C) providing reliable law enforcement intelligence to law enforcement agencies needed to design effective enforcement strategies and operations; and
(D) supporting coordinated law enforcement strategies which maximize use of available resources to reduce the supply of illegal drugs in designated areas and in the United States as a whole.
**(b) Designation**
(1) **In general** — The Director, in consultation with the Attorney General, the Secretary of the Treasury, the Secretary of Homeland Security, heads of the National Drug Control Program agencies, and the Governor of each applicable State, may designate any specified area of the United States as a high intensity drug trafficking area.
(2) **Activities** — After making a designation under paragraph (1) and in order to provide Federal assistance to the area so designated, the Director may—
(A) obligate such sums as are appropriated for the Program;
(B) direct the temporary reassignment of Federal personnel to such area, subject to the approval of the head of the department or agency that employs such personnel;
(C) take any other action authorized under [section 1703 of this title](https://uscode.hou
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1706
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Emerging and Continuing Threats Coordinator** The Director shall designate or appoint a United States Emerging and Continuing Threats Coordinator to perform the duties of that position described in this section and such other duties as may be determined by the Director. For purposes of carrying out the previous sentence, the Director shall designate or appoint an appointee in the Senior Executive Service or an appointee in a position at level 15 of the General Schedule (or equivalent).
**(b) Emerging Threats Committee**
(1) **In general** — The Emerging Threats Committee shall—
(A) monitor evolving and emerging drug threats in the United States;
(B) identify and discuss evolving and emerging drug trends in the United States using the criteria required to be established under paragraph (6);
(C) assist in the formulation of and oversee implementation of any plan described in subsection (d);
(D) provide such other advice to the Coordinator and Director concerning strategy and policies for emerging drug threats and trends as the Committee determines to be appropriate; and
(E) disseminate and facilitate the sharing with Federal, State, local, and Tribal officials and other entities as determined by the Director of pertinent information and data relating to—
(i) recent trends in drug supply and demand;
(ii) fatal and nonfatal overdoses;
(iii) demand for and availability of evidence-based substance use disorder treatment, including the extent of the unmet treatment need, and treatment admission trends;
(iv) recent trends in drug interdiction, supply, and demand from State, local, and Tribal law enforcement agencies; and
(v) other subject matter as determined necessary by the Director.
(2) **Chairperson** — The Director shall des
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1708
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) United States Interdiction Coordinator**
(1) **In general** — The Director shall designate or appoint an appointee in the Senior Executive Service or an appointee in a position at level 15 of the General Schedule (or equivalent) as the United States Interdiction Coordinator to perform the duties of that position described in paragraph (2) and such other duties as may be determined by the Director with respect to coordination of efforts to interdict illicit drugs from entering the United States.
(2) **Responsibilities** — The United States Interdiction Coordinator shall be responsible to the Director for—
(A) coordinating the interdiction activities of the National Drug Control Program agencies to ensure consistency with the National Drug Control Strategy;
(B) on behalf of the Director, developing and issuing, on or before September 1 of each year and in accordance with paragraph (4), a National Interdiction Command and Control Plan to ensure the coordination and consistency described in subparagraph (A);
(C) assessing the sufficiency of assets committed to illicit drug interdiction by the relevant National Drug Control Program agencies; and
(D) advising the Director on the efforts of each National Drug Control Program agency to implement the National Interdiction Command and Control Plan.
(3) **Staff** — The Director shall assign such permanent staff of the Office as he considers appropriate to assist the United States Interdiction Coordinator to carry out the responsibilities described in paragraph (2), and may request that appropriate National Drug Control Program agencies detail or assign staff to assist in carrying out such responsibilities.
(4) **National Interdiction Command and Control Plan**
(A) *Purposes* — The National Interdiction Com
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1710
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Requirement** Each advertisement or other communication paid for by the Office, either directly or through a contract awarded by the Office, shall include a prominent notice informing the target audience that the advertisement or other communication is paid for by the Office.
**(b) Advertisement or other communication** In this section, the term “advertisement or other communication” includes—
(1) an advertisement disseminated in any form, including print or by any electronic means; and
(2) a communication by an individual in any form, including speech, print, or by any electronic means.
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1710a
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
There are authorized to be appropriated to carry out this chapter except activities otherwise specified, to remain available until expended, $18,400,000 for each of fiscal years 2018 through 2023.
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1711
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.